
TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks
JO  - Transfusion
JA  - Transfusion
VL  - 38
IS  - S10
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.1998.tb00056.x
DO  - doi:10.1111/j.1537-2995.1998.tb00056.x
SP  - 1S
EP  - 128S
PY  - 1998
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12251
DO  - doi:10.1111/all.12251
SP  - 337
EP  - 497
PY  - 2013
ER  - 

TY  - JOUR
TI  - Posters
JO  - FEMS Microbiology Letters
VL  - 222
IS  - s1
SN  - 0378-1097
UR  - https://doi.org/10.1016/S0378-1097(03)00297-0
DO  - doi:10.1016/S0378-1097(03)00297-0
SP  - 103
EP  - 505
PY  - 2003
ER  - 

TY  - JOUR
TI  - Proceedings of SCANNING 2001 May 5–7, 2001 New York, New York, USA
JO  - Scanning
JA  - Scanning
VL  - 23
IS  - 2
SN  - 0161-0457
UR  - https://doi.org/10.1002/sca.4950230201
DO  - doi:10.1002/sca.4950230201
SP  - 65
EP  - 157
PY  - 2001
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Pathology International
VL  - 54
IS  - s2
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2004.01762.x
DO  - doi:10.1111/j.1440-1827.2004.01762.x
SP  - A1
EP  - A37
PY  - 2004
ER  - 

TY  - JOUR
TI  - Oral Research Communications of the 22nd ECVIM-CA Congress
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 26
IS  - 6
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12000
DO  - doi:10.1111/jvim.12000
SP  - 1505
EP  - 1538
PY  - 2012
ER  - 

TY  - JOUR
TI  - 42nd Annual Meeting of the German–Speaking Mycological Society (DMykG)
JO  - Mycoses
VL  - 51
IS  - 5
SN  - 0933-7407
UR  - https://doi.org/10.1111/j.1439-0507.2007.01598.x
DO  - doi:10.1111/j.1439-0507.2007.01598.x
SP  - 365
EP  - 436
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts of Papers,** Ninety-second Annual Meeting, Marriott Rivercenter San Antonio, Texas, March 13–15, 1991
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 49
IS  - 2
SN  - 0009-9236
UR  - https://doi.org/10.1038/clpt.1991.18
DO  - doi:10.1038/clpt.1991.18
SP  - 123
EP  - 201
PY  - 1991
AB  - Clinical Pharmacology and Therapeutics (1991) 49, 123?201; doi:10.1038/clpt.1991.18
ER  - 

TY  - JOUR
AU  - Colombo, Graziano
AU  - Clerici, Marco
AU  - Giustarini, Daniela
AU  - Portinaro, Nicola M.
AU  - Aldini, Giancarlo
AU  - Rossi, Ranieri
AU  - Milzani, Aldo
AU  - Dalle-Donne, Isabella
TI  - Pathophysiology of tobacco smoke exposure: Recent insights from comparative and redox proteomics
JO  - Mass Spectrometry Reviews
JA  - Mass Spec Rev
VL  - 33
IS  - 3
SN  - 0277-7037
UR  - https://doi.org/10.1002/mas.21392
DO  - doi:10.1002/mas.21392
SP  - 183
EP  - 218
KW  - tobacco smoke
KW  - inflammation
KW  - (redox) proteomics
KW  - mass spectrometry
KW  - oxidative modifications
KW  - protein oxidation
PY  - 2014
AB  - Abstract First-hand and second-hand tobacco smoke are causally linked to a huge number of deaths and are responsible for a broad spectrum of pathologies such as cancer, cardiovascular, respiratory, and eye diseases as well as adverse effects on female reproductive function. Cigarette smoke is a complex mixture of thousands of different chemical species, which exert their negative effects on macromolecules and biochemical pathways, both directly and indirectly. Many compounds can act as oxidants, pro-inflammatory agents, carcinogens, or a combination of these. The redox behavior of cigarette smoke has many implications for smoke related diseases. Reactive oxygen and nitrogen species (both radicals and non-radicals), reactive carbonyl compounds, and other species may induce oxidative damage in almost all the biological macromolecules, compromising their structure and/or function. Different quantitative and redox proteomic approaches have been applied in vitro and in vivo to evaluate, respectively, changes in protein expression and specific oxidative protein modifications induced by exposure to cigarette smoke and are overviewed in this review. Many gel-based and gel-free proteomic techniques have already been used successfully to obtain clues about smoke effects on different proteins in cell cultures, animal models, and humans. The further implementation with other sensitive screening techniques could be useful to integrate the comprehension of cigarette smoke effects on human health. In particular, the redox proteomic approach may also help identify biomarkers of exposure to tobacco smoke useful for preventing these effects or potentially predictive of the onset and/or progression of smoking-induced diseases as well as potential targets for therapeutic strategies. ? 2013 Wiley Periodicals, Inc. Mass Spec Rev 33: 183?218, 2014.
ER  - 

TY  - JOUR
TI  - Cardiovascular Pharmacology
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 115
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.12259_1
DO  - doi:10.1111/bcpt.12259_1
SP  - 5
EP  - 53
PY  - 2014
ER  - 

TY  - JOUR
TI  - POSTER COMMUNICATIONS
JO  - British Journal of Pharmacology
VL  - 100
IS  - S1
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.1990.tb16988.x
DO  - doi:10.1111/j.1476-5381.1990.tb16988.x
SP  - 377P
EP  - 493P
PY  - 1990
ER  - 

TY  - JOUR
TI  - Workshops
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 9
IS  - S1
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.1997.tb01077.x
DO  - doi:10.1111/j.1468-3083.1997.tb01077.x
SP  - S79
EP  - S111
PY  - 1997
ER  - 

TY  - JOUR
TI  - Annual Symposium of the Society for the Study of Inborn Errors of Metabolism
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 35
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-012-9512-z
DO  - doi:10.1007/s10545-012-9512-z
SP  - 1
EP  - 182
PY  - 2012
ER  - 

TY  - JOUR
TI  - ISLH 2019 Abstracts
JO  - International Journal of Laboratory Hematology
JA  - Int J Lab Hem
VL  - 41
IS  - S2
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.13105
DO  - doi:10.1111/ijlh.13105
SP  - 1
EP  - 205
PY  - 2019
ER  - 

TY  - JOUR
TI  - ORAL COMMUNICATIONS
JO  - British Journal of Pharmacology
VL  - 116
IS  - s1
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.1995.tb16903.x
DO  - doi:10.1111/j.1476-5381.1995.tb16903.x
SP  - 1P
EP  - 82P
PY  - 1995
ER  - 

TY  - JOUR
TI  - POSTER SESSION: BASIC SCIENCE
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 12
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hst008
DO  - doi:10.1093/eurjhf/hst008
SP  - S36
EP  - S72
PY  - 2013
ER  - 

TY  - JOUR
TI  - Communications
JO  - British Journal of Pharmacology
VL  - 97
IS  - S1
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.1989.tb16851.x
DO  - doi:10.1111/j.1476-5381.1989.tb16851.x
SP  - 369P
EP  - 605P
PY  - 1989
ER  - 

TY  - JOUR
TI  - Applications of Modeling & Simulation
JO  - Clinical Pharmacology in Drug Development
JA  - Clinical Pharmacology in Drug Development
VL  - 7
IS  - S1
SN  - 2160-763X
UR  - https://doi.org/10.1002/cpdd.610
DO  - doi:10.1002/cpdd.610
SP  - 1
EP  - 104
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 276
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/j.1742-4658.2009.07049.x
DO  - doi:10.1111/j.1742-4658.2009.07049.x
SP  - 95
EP  - 356
PY  - 2009
ER  - 

TY  - JOUR
TI  - Orals
JO  - Histopathology
VL  - 41
IS  - s1
SN  - 0309-0167
UR  - https://doi.org/10.1046/j.1365-2559.41.s1.1.x
DO  - doi:10.1046/j.1365-2559.41.s1.1.x
SP  - 1
EP  - 63
PY  - 2002
ER  - 
